These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8937289)

  • 1. White-coat hypertension.
    Kristensen KS; Høegholm A
    Lancet; 1996 Nov; 348(9039):1444; author reply 1445-6. PubMed ID: 8937289
    [No Abstract]   [Full Text] [Related]  

  • 2. White-coat hypertension as a cause of cardiovascular dysfunction.
    Glen SK; Elliott HL; Curzio JL; Lees KR; Reid JL
    Lancet; 1996 Sep; 348(9028):654-7. PubMed ID: 8782756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White-coat hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Porcellati C
    Lancet; 1996 Nov; 348(9039):1444-5; author reply 1445-6. PubMed ID: 8937290
    [No Abstract]   [Full Text] [Related]  

  • 4. [White coat hypertension].
    Umei H; Matsuoka H; Imaizumi T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():68-72. PubMed ID: 16981522
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reverse white-coat hypertension].
    Inenaga T; Kawano Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():73-8. PubMed ID: 16981523
    [No Abstract]   [Full Text] [Related]  

  • 6. "Masked" and "white-coat" hypertension could signal more serious complications. Experiencing temporary spikes in blood pressure may put you at greater risk of cardiac events.
    Heart Advis; 2009 Nov; 12(11):6. PubMed ID: 21192380
    [No Abstract]   [Full Text] [Related]  

  • 7. [Difference in blood pressure measured in the office and out of office].
    Kuwajima I
    Nihon Rinsho; 2008 Aug; 66(8):1531-6. PubMed ID: 18700553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term risk in subjects with white-coat hypertension.
    Obara T; Ohkubo T; Imai Y
    Hypertension; 2009 Nov; 54(5):e133; author reply e134. PubMed ID: 19786645
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic criteria for white-coat hypertension].
    Eguchi K; Kario K; Shimada K
    Nihon Naika Gakkai Zasshi; 2003 Feb; 92(2):202-7. PubMed ID: 12652722
    [No Abstract]   [Full Text] [Related]  

  • 10. White-coat hypertension.
    Krakoff LR; Phillips RA
    Lancet; 1996 Nov; 348(9039):1443-4; author reply 1445-6. PubMed ID: 8937288
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prognostic importance of white coat and masked hypertension].
    Gustavsen P; Hansen TW
    Ugeskr Laeger; 2009 Jun; 171(24):2019-22. PubMed ID: 19523366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White coat effect in treated hypertensive patients: sex differences.
    Myers MG; Reeves RA
    J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home blood pressure as a cardiovascular outcome predictor: it's time to take this method seriously.
    Stergiou GS; Siontis KC; Ioannidis JP
    Hypertension; 2010 Jun; 55(6):1301-3. PubMed ID: 20385967
    [No Abstract]   [Full Text] [Related]  

  • 14. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
    Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
    J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White-coat hypertension in adults.
    Angeli F; Verdecchia P; Gattobigio R; Sardone M; Reboldi G
    Blood Press Monit; 2005 Dec; 10(6):301-5. PubMed ID: 16496443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
    Salles GF; Cardoso CR; Muxfeldt ES
    Arch Intern Med; 2008 Nov; 168(21):2340-6. PubMed ID: 19029499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
    Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
    Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of the white-coat effect in hypertensive subjects.
    Mansoor GA; McCabe EJ; White WB
    J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ['Office' or 'white-coat hypertension'].
    Janssen MC; Thien T
    Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2401-4. PubMed ID: 8524418
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing white-coat effect.
    Handler J
    J Clin Hypertens (Greenwich); 2008 Aug; 10(8):649-54. PubMed ID: 18772650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.